MacroGenics and Eliance: Acknowledging Weakness Led to Counting Blessings
This article was originally published in Start Up
Executive Summary
An increasingly popular recipe for reducing risk calls for merging young companies. The recent acquisition by MacroGenics of Eliance Biotechnology reduces both management and financial risk, while creating a more integrated technology platform with broader potential than either company's alone.